Nigerian Doctor In U.S, Babafemi Taiwo Leads Major Study On Antiviral Covid-19 Drug Remdesivir
A bright doctor from the West African country of Nigeria Babafemi Taiwo is leading part of major study on antiviral drug Remdesivir appearing to treat COVID-19, the potentially deadly respiratory disease caused by the coronavirus, which has killed more than 200,000 people around the world.
CNN interviewed Dr Babafemi Taiwo to discuss the result of Remdesivir in treating Coronavirus.
Preliminary results of Remdesivir show it can help hospitalized COVID-19 patients recover faster.
Though Remdesivir, an antiviral drug made by Gilead Sciences, appears to help patients with Coronavirus recover faster, it does not significantly reduce death, according to preliminary data from the National Institutes of Health.
“The data shows that Remdesivir has a clear cut, significant, positive effect in diminishing, the time of recovery,” the director of the National Institute of Allergy and Infectious Diseases, Dr Anthony Fauci said during a meeting between president Trump and Louisiana Governor John Bel Edwards.
Below is a video of Dr Babafemi Taiwo speaking to CNN about the promising results of Remdesivir in treating COVID-19.
Click To Share This Post